connect how-science-can-help-feed-the-future 
XTalks
JANUARY 5, 2022
Life science organizations are facing immense pressure by the government, the general public and regulators due to COVID-19 and its emerging variants. The global disruption within the life science and healthcare fields calls for new and improved talent strategies. The terms, talent community and talent pool can be used interchangeably.
pharmaphorum
AUGUST 3, 2022
Since then, progress has been slow, but the industry now has everything it needs to close the feedback loop between science, evidence, and care, said speakers at a recent Conference Forum webinar. More than a technology problem. If it were just a technology problem, we would have solved it by now. There are other factors involved.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 30, 2020
The two potent, virus-neutralizing antibodies that form REGN-COV2 bind non-competitively to the critical receptor binding domain of the virus’s spike protein, which diminishes the ability of mutant viruses to escape treatment and protects against spike variants that have arisen in the human population, as detailed in Science.
Drug Discovery World
OCTOBER 5, 2022
It’s an incredibly exciting time in the life sciences – with a focus on collaboration across disciplines the sky is the limit and the opportunities to create diagnostic tools and therapeutics that could benefit society as a whole are innumerable. Q: What do you see as being the driver for the renaissance in the life sciences?
The Pharma Data
JANUARY 12, 2021
“COVID-19 continues to sicken hundreds of thousands of Americans every day and the people of Regeneron are committed to help,” said Leonard S. . “COVID-19 continues to sicken hundreds of thousands of Americans every day and the people of Regeneron are committed to help,” said Leonard S. New agreement covers 1.25
Drug Discovery World
AUGUST 10, 2023
In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months – and explore some of the most prominent themes and priorities seen throughout 2023.
The Pharma Data
OCTOBER 28, 2020
Today’s analysis, involving more than 500 additional patients, prospectively confirms that REGN-COV2 can indeed significantly reduce viral load and further shows that these viral reductions are associated with a significant decrease in the need for further medical attention,” said George D. Yancopoulos , M.D.,
Expert insights. Personalized for you.
104 
Let's personalize your content